These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 19366621

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Exacerbation of Plasmodium yoelii malaria in Echinostoma caproni infected mice and abatement through anthelmintic treatment.
    Noland GS, Graczyk TK, Fried B, Fitzgerald EJ, Kumar N.
    J Parasitol; 2005 Aug; 91(4):944-8. PubMed ID: 17089770
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatosplenomegaly in Kenyan schoolchildren: exacerbation by concurrent chronic exposure to malaria and Schistosoma mansoni infection.
    Wilson S, Vennervald BJ, Kadzo H, Ireri E, Amaganga C, Booth M, Kariuki HC, Mwatha JK, Kimani G, Ouma JH, Muchiri E, Dunne DW.
    Trop Med Int Health; 2007 Dec; 12(12):1442-9. PubMed ID: 18076550
    [Abstract] [Full Text] [Related]

  • 8. Increased parasitaemia and delayed parasite clearance in Schistosoma mansoni and Plasmodium berghei co-infected mice.
    Legesse M, Erko B, Balcha F.
    Acta Trop; 2004 Jul; 91(2):161-6. PubMed ID: 15234665
    [Abstract] [Full Text] [Related]

  • 9. Exposure to malaria affects the regression of hepatosplenomegaly after treatment for Schistosoma mansoni infection in Kenyan children.
    Booth M, Vennervald BJ, Butterworth AE, Kariuki HC, Amaganga C, Kimani G, Mwatha JK, Otedo A, Ouma JH, Dunne DW.
    BMC Med; 2004 Sep 27; 2():36. PubMed ID: 15450118
    [Abstract] [Full Text] [Related]

  • 10. Anaemia in mice with concomitant Schistosoma mansoni and Plasmodium berghei yoelii infection.
    Lewinsohn R.
    Trans R Soc Trop Med Hyg; 1975 Sep 27; 69(1):51-6. PubMed ID: 1096378
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined chemotherapy manifest less severe immunopathology effects in helminth-protozoa comorbidity.
    Khayeka-Wandabwa C, Zhou G, Magak NG, Choge JK, Kemei WK, Makwali JA, Karani LW, Kisavi MP, Ndulu JV, Anjili CO.
    Exp Parasitol; 2019 Sep 27; 204():107728. PubMed ID: 31348915
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni.
    Vennervald BJ, Booth M, Butterworth AE, Kariuki HC, Kadzo H, Ireri E, Amaganga C, Kimani G, Kenty L, Mwatha J, Ouma JH, Dunne DW.
    Trans R Soc Trop Med Hyg; 2005 Feb 27; 99(2):150-60. PubMed ID: 15607341
    [Abstract] [Full Text] [Related]

  • 20. Tandem repeat recombinant proteins as potential antigens for the sero-diagnosis of Schistosoma mansoni infection.
    Kalenda YD, Kato K, Goto Y, Fujii Y, Hamano S.
    Parasitol Int; 2015 Dec 27; 64(6):503-12. PubMed ID: 26148816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.